|4Mar 30, 1:25 PM ET

Hrynkow Sharon Hemond 4

4 · Cyclo Therapeutics, Inc. · Filed Mar 30, 2021

Insider Transaction Report

Form 4
Period: 2021-03-29
Hrynkow Sharon Hemond
SVP for Medical Affairs
Transactions
  • Purchase

    Common Stock

    2021-03-29$7.46/sh+1,000$7,46018,350 total

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4